Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -20.00% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?